| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 58.92B | 45.90B | 39.46B | 39.51B | 38.12B | 39.45B |
| Gross Profit | 21.46B | 19.94B | 19.53B | 19.73B | 19.66B | 20.80B |
| EBITDA | 4.01B | 3.32B | 3.29B | 3.25B | 3.10B | 4.29B |
| Net Income | 1.49B | 1.38B | 1.30B | 1.15B | 1.49B | 1.62B |
Balance Sheet | ||||||
| Total Assets | 68.00B | 66.49B | 50.64B | 50.21B | 56.88B | 53.00B |
| Cash, Cash Equivalents and Short-Term Investments | 1.69B | 1.71B | 1.58B | 1.80B | 2.90B | 3.23B |
| Total Debt | 15.50B | 14.91B | 24.00M | 39.00M | 70.00M | 112.00M |
| Total Liabilities | 28.78B | 27.55B | 12.04B | 11.99B | 13.96B | 13.45B |
| Stockholders Equity | 39.22B | 38.94B | 38.60B | 38.21B | 42.92B | 39.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.26B | 1.79B | 2.26B | 1.44B | 5.98B |
| Operating Cash Flow | 0.00 | 3.02B | 2.67B | 3.10B | 1.87B | 6.63B |
| Investing Cash Flow | 0.00 | -10.54B | -1.10B | -2.37B | 106.00M | -2.17B |
| Financing Cash Flow | 0.00 | 7.65B | -1.79B | -1.83B | -1.82B | -2.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥19.42T | 29.11 | 19.84% | 0.90% | 9.56% | 16.37% | |
72 Outperform | ¥40.77B | -29.01 | ― | 3.62% | -0.98% | -29.86% | |
72 Outperform | ¥71.07B | 3.05 | ― | 2.73% | 10.48% | -34.38% | |
70 Outperform | ¥263.70B | 19.60 | ― | 1.46% | 12.02% | -15.70% | |
68 Neutral | ¥733.67B | 16.45 | 8.48% | 2.02% | ― | ― | |
66 Neutral | ¥38.93B | 20.05 | ― | 4.71% | 48.00% | 16.54% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |